Skip to main content

Closed

CSBR: Champions Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+13.5% / yr

Operating margin-1.9%

ROIC-13.2%

Financially safe

Stretched

Debt / equity1.17×

Interest coverage0.0×

Current ratio0.96×

Champions Oncology, Inc.

CSBRNASDAQ Capital Market·USD·Closed

Champions Oncology, Inc.

CSBRNASDAQ·USD·Closed

$5.36

+1.90%

$5.36

+$0.10 (1.90%)

52W Range

4thpctl

Volume

0.22×avg

Mkt Cap

74.47MUSD

P/E

-67.0TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.22×avg

Market Cap

74.47MUSD

P/E Ratio

-67.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings